Status:
COMPLETED
A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension
Lead Sponsor:
Innovative Medical
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Evaluate the incidence of hyperemia in patients using bimatoprost and to determine if simple interventions reduce its incidence and to assess the value of detailed instruction in increasing patient co...
Eligibility Criteria
Inclusion
- · Male or female \> 18 years of age
- No prior use of bimatoprost
- Diagnosis of open-angle glaucoma or ocular hypertension
- Ability to provide informed consent and likely to complete all study visits
Exclusion
- · Known contraindication to bimatoprost
- Uncontrolled systemic disease
- Active ocular disease other than glaucoma or ocular hypertension
- Required use of ocular medications other than the study medications during the study (intermittent use of artificial tear solutions will be permitted)
- History of intraocular surgery within the last 3 months
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00348062
Last Update
June 1 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Noecker
Pittsburgh, Pennsylvania, United States, 15213